Liposomal antisense oligonucleotides for cancer therapy.
Siwak
Doris R
DR
Department of Bioimmunotherapy, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA.
Tari
Ana M
AM
Lopez-Berestein
Gabriel
G
D000818:Animals; D001483:Base Sequence; D001943:Breast Neoplasms / Q000235:genetics / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D045744:Cell Line, Tumor; D002645:Chickens; D016503:Drug Delivery Systems / Q000379:methods; D005260:Female; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D008081:Liposomes / Q000138:chemical synthesis / Q000737:chemistry; D009369:Neoplasms / Q000235:genetics* / Q000628:therapy; D016376:Oligonucleotides, Antisense / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use*; D010713:Phosphatidylcholines; D013937:Thymidine Kinase / Q000037:antagonists & inhibitors / Q000235:genetics
D008081:Liposomes; D016376:Oligonucleotides, Antisense; D010713:Phosphatidylcholines; D013937:Thymidine Kinase; C017251:1,2-oleoylphosphatidylcholine